Print this page
Pfizer relocates to Croatia Pfizer relocates to Croatia

Pfizer relocates from Australia to Croatia

By  Feb 22, 2017

One of the world's premier biopharmaceutical companies Pfizer has announced closing of its plant in Australia in order to move production to Croatia.

According to the press release from Ziva Janez Visnar, the Pfizer spokeswoman for the Adriatic region, the pharmaceutical company headquartered in New York has decided to shut down its Hospira facility in the city of Adelaide and relocate the production to the Croatian capital of Zagreb by the end of 2021.

''Adelaide produces the healing substance PEGfilgrastim which is then shipped to Zagreb for pegylation and filling into pre-filled syringes. The manufacturing of the PEGfilgrastim will be transferred to Croatia'', commented Visnar.

Pfizer was founded in 1849 in New York City as a manufacturer of fine chemicals. The company develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Pfizer currently employs more than 80,000 people around the globe, whilst its revenue in 2016 was $52,8 billion.